O. JOSEPH BIZZOZERO JR., M.D.; KENNETH G. JOHNSON, M.D.; ANTONIO CIOCCO, SC.D.; SHO KAWASAKI, M.D.; SHIGEKI TOYODA, M.D.
Recently, we reported on the experience of the Atomic Bomb Casualty Commission (ABCC) in the detection of leukemia in the populations of Hiroshima and Nagasaki, Japan, for the period 1946 to 1964 (1). The years 1946 to 1954 exhibited extremely high incidence rates for leukemia in those persons exposed 0 to 1,500 m from the atomic bombs' hypocenters. This period reflected maximal radiation effect. In addition, attention was invited both to the induction of chronic leukemia at a remarkably high rate in persons who were less than 30 years of age at the time of the bombings (ATB) and to
BIZZOZERO OJ, JOHNSON KG, CIOCCO A, et al. Radiation-related Leukemia in Hiroshima and Nagasaki 1946-1964: II. Observations on Type-specific Leukemia, Survivorship, and Clinical Behavior. Ann Intern Med. 1967;66:522–530. doi: 10.7326/0003-4819-66-3-522
Download citation file:
Published: Ann Intern Med. 1967;66(3):522-530.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use